David Ricks, Eli Lilly CEO (Jeenah Moon/Bloomberg via Getty Images)
Eli Lilly misses 2024 revenue expectations, stock dips 7%
Eli Lilly expects to miss its recent revenue estimate for 2024 by about $400 million, according to a preliminary report.
The company’s estimates have varied …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.